Healthcare
SEC Form 4 insider trading activity in this sector
The Healthcare sector recorded 2,743 SEC Form 4 filings across 483 companies in the last 90 days. Most recent filing: Sep 1, 2026.
Activity summary · last 30 days 303 companies · 1,055 filings
Bought
$266.1M
Sold
$2.5B
Net flow
$2.2B
Companies in this sector
| Source | |||||||
|---|---|---|---|---|---|---|---|
| XENE | Chief Medical Officer | Sale | 7,068 | $426K | Sep 1 | SEC ↗ | |
| FENC | Chief Medical Officer | Sale | 12,000 | $146K | Sep 1 | SEC ↗ | |
| GRAL | Chief Executive Officer | Sale | 5,000 | $425K | Sep 1 | SEC ↗ | |
| GRAL | Chief Financial Officer | Sale | 7,900 | $672K | Sep 1 | SEC ↗ | |
| ARTV | Chief Medical Officer | Sale | 8,222 | $99K | Aug 31 | SEC ↗ | |
| JAZZ | EVP, Global Head of R&D & CMO | Sale | 76,921 | $19.2M | Aug 31 | SEC ↗ | |
| MAZE | CSBO | Sale | 7,500 | $207K | Aug 31 | SEC ↗ | |
| TRDA | 10% Owner | Sale | 38,922 | $280K | Aug 31 | SEC ↗ | |
| TRDA | 10% Owner | Sale | 3,733 | $26K | Aug 31 | SEC ↗ | |
| TRDA | 10% Owner | Sale | 44,259 | $309K | Aug 31 | SEC ↗ | |
| SLGL | 10% Owner | Purchase | 35,113 | $2.4M | Aug 31 | SEC ↗ | |
| SLGL | 10% Owner | Purchase | 5,217 | $356K | Aug 31 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 10,000 | $702K | Aug 31 | SEC ↗ | |
| CYTK | President & CEO | Sale | 7,500 | $527K | Aug 31 | SEC ↗ | |
| SRTS | Director | Purchase | 37,537 | $129K | Aug 31 | SEC ↗ | |
| SRTS | Director | Purchase | 27,304 | $97K | Aug 31 | SEC ↗ | |
| AURX | CEO/CFO | Purchase | 789 | $844 | Aug 31 | SEC ↗ | |
| AURX | CEO/CFO | Purchase | 7,984 | $9K | Aug 31 | SEC ↗ | |
| MTD | President and CEO | Sale | 942 | $1.3M | Aug 31 | SEC ↗ | |
| TNXP | Chief Executive Officer | Purchase | 2,000 | $28K | Aug 31 | SEC ↗ | |
| ALZN | Director | Sale | 2,000 | $3K | Aug 31 | SEC ↗ | |
| ALZN | Director | Purchase | 110,388 | $111K | Aug 31 | SEC ↗ | |
| CTTH | CEO | Purchase | 3,500 | $172 | Aug 31 | SEC ↗ | |
| ICUI | Chief Financial Officer | Sale | 9,307 | $1.6M | Aug 31 | SEC ↗ | |
| ETON | Director | Sale | 50,000 | $3.0M | Aug 31 | SEC ↗ |